Finance

Beta
Lists
206640:KOSDAQ
Boditech Med Inc
â‚©10,120.00
-6.21%
(-670.00) 1D
Jun 8, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 206640...
Open
â‚©10,420
High
â‚©10,420
Low
â‚©10,110
Mkt. cap
221.71B
Avg. vol.
50.68K
Volume
33.32K
Dividend
1.48%
Quarterly dividend
â‚©38
Ex-dividend date
Mar 31, 2026
P/E ratio
8.45
52-wk high
â‚©16,100
52-wk low
â‚©10,110
EPS
â‚©1,198
Shares outstanding
21.91M
No. of employees
541
Open
â‚©10,420
High
â‚©10,420
Low
â‚©10,110
Mkt. cap
221.71B
Avg. vol.
50.68K
Volume
33.32K
Dividend
1.48%
Quarterly dividend
â‚©38
Ex-dividend date
Mar 31, 2026
P/E ratio
8.45
52-wk high
â‚©16,100
52-wk low
â‚©10,110
EPS
â‚©1,198
Shares outstanding
21.91M
No. of employees
541
News stories
From sources across the web
About Boditech Med Inc
CEOChoi Eui-yeol
Employees541
Founded1998
Headquarters-
SectorMedical device
Websiteboditech.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
41.48B
39.95B
41.57B
42.85B
Cost of goods sold
17.68B
15.95B
17.76B
18.00B
Cost of revenue
17.68B
15.95B
17.76B
18.00B
Research and development expenses
4.58B
4.68B
4.89B
5.45B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.36B
11.12B
11.33B
11.00B
Operating expense
14.87B
17.12B
18.75B
18.04B
Total operating expenses
32.54B
33.07B
36.51B
36.04B
Operating income
8.94B
6.88B
5.05B
6.80B
Other non operating income
133.50M
316.49M
309.71M
1.51B
EBT including unusual items
8.60B
9.63B
853.86M
11.98B
EBT excluding unusual items
8.39B
9.34B
1.62B
11.88B
Income tax expense
1.14B
1.82B
-502.71M
2.48B
Effective tax rate
13.25%
18.89%
-58.87%
20.69%
Other operating expenses
247.71M
335.64M
286.58M
263.55M
Net income
7.34B
7.79B
1.27B
9.59B
Net profit margin
17.70%
19.51%
3.05%
22.38%
Earnings per share
-
-
-
-
Interest and investment income
86.45M
83.16M
64.32M
88.71M
Interest expense
-87.99M
-83.10M
-156.66M
-166.59M
Net interest expenses
-1.54M
60.00K
-92.34M
-77.88M
Depreciation and amortization charges
839.63M
925.02M
1.02B
1.02B
EBITDA
11.57B
9.34B
7.68B
9.22B
Gain or loss from assets sale
12.55M
21.10M
-47.54M
115.69M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer